XML 351 R14.htm IDEA: XBRL DOCUMENT v3.25.0.1
Investments In Subsidiaries
12 Months Ended
Dec. 31, 2024
Disclosure of subsidiaries [abstract]  
Note 8 - Investments in Subsidiaries
Note 8 - Investments in Subsidiaries
 
  A.
Non-controlling interests in subsidiaries
 
The following tables present information with respect to non-controlling interests in a subsidiary, YPH (at the rate of 50%), before elimination of inter-company transactions. The information includes fair value adjustments that were made on the acquisition date, other than goodwill and presented without adjustments for the ownership rates held by the Company.
 
 
As of December 31
 
2024
2023
 
$ millions
$ millions
 
Current assets
270
278
Non-current assets
365
376
Current liabilities
(96)
(102)
Non-current liabilities
(38)
(43)
Equity
(501)
(509)

 
 
For the year ended December 31
 
2024
2023
2022
 
$ millions
$ millions
$ millions
 
Sales
579
546
723
Operating Income
152
105
146
Depreciation and amortization
37
33
34
Operating income before depreciation and amortization
189
138
180
Net Income
114
85
116
Total Comprehensive income
103
71
78

 
B. Business Acquisition and Divestiture
 
  (1)
In the beginning of 2024, the Company completed the acquisition of Nitro 1000, a manufacturer, developer and provider of biological crop inputs in Brazil, for a consideration of $30 million. Nitro 1000’s products mainly target soybean, corn and sugar cane crops, and their application replaces or optimizes the use of fertilizers. These products help farmers increase profitability, as well as offer more sustainable options.
 
  (2)
In July 2024, the Company completed the acquisition of Custom Ag Formulators (hereinafter - CAF), a North American provider of agriculture formulations and products customized for growers, for a total consideration of $60 million, including a performance based earnout of up to $10 million. CAF offers a diverse assortment of liquid adjuvants and enhanced nutrients, as well as various other specialty products.